Evercore ISI is adding Cardinal Health to the firm’s “Tactical Outperform” list ahead of Q2 EPS from the Healthcare Technology & Distribution group. Despite the Optum contract loss, an FY25 EPS floor of $7.50-plus “should be largely achievable,” says the firm, which has an In Line rating and $105 price target on Cardinal Health shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH: